Myasthenia gravis.
dc.contributor.author | Anandam, R | en_US |
dc.date.accessioned | 1989-03-01 | en_US |
dc.date.accessioned | 2009-05-30T11:25:52Z | |
dc.date.available | 1989-03-01 | en_US |
dc.date.available | 2009-05-30T11:25:52Z | |
dc.date.issued | 1989-03-01 | en_US |
dc.description.abstract | Twelve children with myasthenic symptoms were seen over a period of 6 years. The age of onset of symptoms ranged from 6 months to 9 years. On followup for a mean period of 4.25 years, (longest followup was 9 years) five children went into complete remission of symptoms after treatment with prostigmine; three children responded to prostigmine and steroids; two children were relieved of symptoms without prolonged treatment and the remaining two children could not be followed up. Thymectomy was not advised in any patient. | en_US |
dc.identifier.citation | Anandam R. Myasthenia gravis. Indian Journal of Pediatrics. 1989 Mar-Apr; 56(2): 277-82 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/79667 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://medind.nic.in/icb/icbai.shtml | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Glucocorticoids --therapeutic use | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Myasthenia Gravis --congenital | en_US |
dc.subject.mesh | Neostigmine --therapeutic use | en_US |
dc.subject.mesh | Remission Induction | en_US |
dc.title | Myasthenia gravis. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1